Filing Details
- Accession Number:
- 0000950103-10-003253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-04 13:59:43
- Reporting Period:
- 2010-11-03
- Filing Date:
- 2010-11-04
- Accepted Time:
- 2010-11-04 13:59:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1013238 | Aradigm Corp | ARDM | Electromedical & Electrotherapeutic Apparatus (3845) | 943133088 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 353278 | S A Nordisk Novo | Novo Alle Dk 2880 Bagsvaerd G7 00000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Disposition | 2010-11-03 | 250,000 | $0.16 | 26,830,591 | No | 4 | S | Indirect | By Novo Nordisk Inc. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Novo Nordisk Inc. |
Footnotes
- The securities were sold in 2 trade lots with the price ranging from USD 0.1600 per share to USD 0.1650 per share (100,000 shares sold at USD 0.1600 per share, 150,000 shares sold at 0.1650 per share).
- Novo Nordisk Inc. is a wholly-owned subsidiary of Novo Nordisk A/S. Novo Nordisk A/S directly holds 26,204,122 shares of common stock of Aradigm Corporation. In addition, Novo Nordisk Inc. holds 626,469 shares of common stock of Aradigm Corporation.
Billionaire Hedge Funds
